Abstract
6-Chloro,6-dehydro,17α-acetoxyprogesterone (RS-1280) is a potent progestational agent, hence it was studied to determine whether or not it was an aldosterone antagonist. The study was carried out in 5 patients with cirrhosis of the liver and ascites, under constant metabolic conditions, with a previous examination of the renal capacity of each patient to excrete water, sodium and potassium under basal conditions and also when benzothiadiazine and mercurial diuretics were administered. In each case, RS-1280 was administered and its effect compared with that of a known aldosterone antagonist (spironolactone). By this means it was demonstrated that RS-1280 has no anti-aldosterone action, although it has a natriuretic effect in cirrhotic patients with a normal capacity to excrete sodium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Clinical Endocrinology & Metabolism
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
